The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

Current guidelines suggest that HIV-infected patients should receive chemoprophylaxis against Pneumocystis jirovecii pneumonia (PJP) if they have a cluster determinant 4 (CD4) count <200 cells/mm 3 or oropharyngeal candidiasis. Persons with CD4 percentage (CD4%) below 14% should also be considere...

Full description

Bibliographic Details
Main Authors: Henry Anyimadu MD, Chandra Pingili MD, Vel Sivapalan MD, Yael Hirsch-Moverman PhD, Sharon Mannheimer MD
Format: Article
Language:English
Published: SAGE Publishing 2018-03-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/2325958218759199

Internet

https://doi.org/10.1177/2325958218759199

Similar Items